Search research articles
Contact Us
Filters
Showing results (1-10 of 117) with videos related to
Page
of 12
Sort By:
Clinical and Laboratory Haematology
|
March 1, 1995
Platelet size analysis in the quality assurance of platelet concentrates for transfusion
A Farrugia
Platelets
|
November 4, 2010
Platelet concentrates for transfusion-metabolic and storage aspects
A Farrugia
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 16, 2002
Risk of variant Creuzfeldt-Jakob disease from factor concentrates: current perspectives
A Farrugia
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
October 14, 2004
Product delivery in the developing world: options, opportunities and threats
A Farrugia
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|
June 22, 2020
Plasma from donors convalescent from SARS-CoV-2 infection-A matter of priorities
A Farrugia
Blood
|
May 15, 1992
Purity of factor VIII concentrates and immune function in hemophiliacs
A Farrugia
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 19, 2017
Time to review the way we estimate access to haemophilia concentrates worldwide
A Farrugia
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
July 3, 2004
Safety and supply of haemophilia products: worldwide perspectives
A Farrugia
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
October 14, 2004
Regulatory challenges to global harmonization and expanded access to concentrates: how will regulators balance the increasing cost of new safety requirements with the desire to increase the availability of affordable product?
A Farrugia
Australasian Biotechnology
|
January 1, 1993
Biotechnology and the plasma fractionation industry--the impact of advances in the production of coagulation factor VIII
A Farrugia
Page
of 12
Search research articles
Search
Showing results (1-10 of 117) with videos related to
Sort By:
Page
of 12
Clinical and Laboratory Haematology
|
March 1, 1995
Platelet size analysis in the quality assurance of platelet concentrates for transfusion
A Farrugia
Platelets
|
November 4, 2010
Platelet concentrates for transfusion-metabolic and storage aspects
A Farrugia
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 16, 2002
Risk of variant Creuzfeldt-Jakob disease from factor concentrates: current perspectives
A Farrugia
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
October 14, 2004
Product delivery in the developing world: options, opportunities and threats
A Farrugia
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|
June 22, 2020
Plasma from donors convalescent from SARS-CoV-2 infection-A matter of priorities
A Farrugia
Blood
|
May 15, 1992
Purity of factor VIII concentrates and immune function in hemophiliacs
A Farrugia
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 19, 2017
Time to review the way we estimate access to haemophilia concentrates worldwide
A Farrugia
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
July 3, 2004
Safety and supply of haemophilia products: worldwide perspectives
A Farrugia
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
October 14, 2004
Regulatory challenges to global harmonization and expanded access to concentrates: how will regulators balance the increasing cost of new safety requirements with the desire to increase the availability of affordable product?
A Farrugia
Australasian Biotechnology
|
January 1, 1993
Biotechnology and the plasma fractionation industry--the impact of advances in the production of coagulation factor VIII
A Farrugia
Page
of 12